No record found
* Returns not adjusted for payouts
Company Profile
Hoechst Pakistan Limited is a public limited Company incorporated in Pakistan under the repealed Companies Act, 1913 (Now the Companies Act, 2017). The Company is engaged in the manufacturing, selling and trading of pharmaceutical and related products. The Company has changed its name from Sanofi-Aventis Pakistan Limited to Hoechst Pakistan Limited.
Sajjad Iftikhar | CEO |
Syed Babar Ali | Chairperson |
Syed Muhammad Taha Naqvi | Company Secretary |
FAMCO Share Registration Services (Private) Limited, 8-F, Near Hotel Faran, Nursery Block-6, P.E.C.H.S., Shahrah-e-Faisal, Karachi
M/s/ A.F. Ferguson & Co. Chartered Accountants
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Apr 30, 2024 | Transmission of Quarterly Report for the Period Ended March 31, 2024 | View PDF |
Apr 24, 2024 | Financial Results for the Quarter Ended March 31, 2024 | View PDF |
Mar 18, 2024 | Transmission of Annual Report for the Year Ended December 31, 2023 | View PDF |
Feb 22, 2024 | FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 | View PDF |
Oct 30, 2023 | Transmission of Financial Statements for the Nine-Months Period Ended September 30, 2023 | View PDF |
Date | Title | Document |
---|---|---|
Apr 16, 2024 | BOARD MEETING AND ANNOUNCEMENT OF CLOSED PERIOD | View PDF |
Apr 8, 2024 | True Copy of Resolution(s) Passed and Adopted at the Annual General Meeting | View PDF |
Apr 1, 2024 | BALLOT PAPER FOR VOTING THROUGH POST IN ANNUAL GENERAL MEETING | View PDF |
Mar 29, 2024 | BALLOT PAPER FOR VOTING THROUGH POST IN ANNUAL GENERAL MEETING (PRE-PUBLICATION) | View PDF |
Mar 18, 2024 | Notice of Annual General Meeting - HPL 2023 | View PDF |
Mar 15, 2024 | NOTICE OF ANNUAL GENERAL MEETING (PRE-PUBLICATION) | View PDF |
Feb 15, 2024 | BOARD MEETING AND ANNOUNCEMENT OF CLOSED PERIOD | View PDF |
Date | Title | Document |
---|---|---|
Apr 23, 2024 | Credit of Final Cash Dividend | View PDF |
Apr 22, 2024 | HPL | Hoechst Pakistan Limited (Formerly: Sanofi-Aventis Pak. Ltd.) - Notice of Credit of Final Cash Dividend (Pre-Publication) | |
Apr 4, 2024 | CORPORATE BRIEFING SESSION | View PDF |
Jan 3, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Jan 2, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Jan 2, 2024 | CHANGE OF COMPANY WEBSITE | View PDF |
Jan 1, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Jan 1, 2024 | NOTICE TO SHAREHOLDERS REGARDING TRANSFER OF SHARES REGISTRAR / TRANSFER AGENT SERVICES (POST-PUBLICATION) | View PDF |
Dec 29, 2023 | NOTICE TO SHAREHOLDERS REGARDING TRANSFER OF SHARES REGISTRAR / TRANSFER AGENT SERVICES (PRE-PUBLICATION) | View PDF |
Dec 29, 2023 | TRANSFER OF SHARES REGISTRAR / TRANSFER AGENT SERVICES | View PDF |
Nov 2, 2023 | Change of Company Secretary | View PDF |
Financials
All numbers in thousands (000's) except EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Sales | 21,368,949 | 18,559,884 | 15,880,932 | 14,107,802 |
Profit after Taxation | 360,807 | 166,783 | 905,952 | 493,067 |
EPS | 37.41 | 17.29 | 93.93 | 51.12 |
Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | |
---|---|---|---|---|
Sales | 6,287,309 | 5,831,380 | 5,285,241 | 4,762,608 |
Profit after Taxation | 335,816 | 469,498 | (165,187) | (357,143) |
EPS | 34.82 | 48.68 | (17.13) | (37.03) |
Ratios
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Gross Profit Margin (%) | 25.86 | 26.24 | 25.96 | 26.97 |
Net Profit Margin (%) | 1.69 | 0.90 | 5.70 | 3.49 |
EPS Growth (%) | 116.37 | (81.59) | 83.74 | 218.50 |
PEG | 0.28 | (0.68) | 0.11 | 0.07 |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
February 22, 2024 4:37 PM | 31/12/2023(YR) | 300%(F) (D) | 02/04/2024 - 08/04/2024 |